Autopsy report · NCT00813878
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Cause of deathSlow enrollment
“Closed due to low accrual”
Life of this trial
- Registered 7 years 5 months after it had already started.
- Ran for about 11 years 2 months before it stopped.
- 126 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- City of Hope Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer
- Interventions
- protein analysis; protein expression analysis; proteomic profiling; diagnostic laboratory biomarker analysis; immunohistochemistry staining method; liquid chromatography
- Participants
- 126
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
“Closed due to very slow accrual” - Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
“Closed early due to low accrual.” - S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium
“Permanently Closed Due to Poor Accrual” - Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients
“Closed prematurely because the accrual was not achieved” - Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
“Closed early due to poor accrual.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.